{"disease":{"id":"bacteremia-due-to-staphylococcus-aureus","name":"bacteremia due to staphylococcus aureus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03248063","title":"Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia","phase":"NA","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05184764","title":"Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Armata Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05329168","title":"ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Lysovant","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}